(Q35560309)

English

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders. part 2: maintenance treatment of major depressive disorder-update 2015.

scientific article published on February 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders. part 2: maintenance treatment of major depressive disorder-update 2015. (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

biological psychiatry

1 reference

based on heuristic

inferred from title

Hans-Jürgen Möller

6

object named as

Hans-Jürgen Möller

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Peter C. Whybrow

4

object named as

Peter C Whybrow

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

1

object named as

Michael Bauer

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Emanuel Severus

2

object named as

Emanuel Severus

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

5

object named as

Jules Angst

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

author name string

Stephan Köhler

3

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Wfsbp Task Force on Treatment Guidelines for Unipolar Depressive Disorders

7

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

publication date

1 February 2015

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

World Journal of Biological Psychiatry

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

16

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

76-95

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Vagus nerve stimulation therapy randomized to different amounts of electrical charge for treatment-resistant depression: acute and chronic effects

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

Antidepressant-induced mania and cycle acceleration: a controversy revisited

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2000 British Association for Psychopharmacology guidelines

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 1993 British Association for Psychopharmacology guidelines. British Association for Psychopharmacology

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

Should depression be managed as a chronic disease?

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

Evidence-based definitions of bipolar-I and bipolar-II disorders among 5,635 patients with major depressive episodes in the Bridge Study: validity and comorbidity

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

Diagnostic conversion from depression to bipolar disorders: results of a long-term prospective study of hospital admissions

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

Antidepressant-associated mood-switching and transition from unipolar major depression to bipolar disorder: A review

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders - first revision

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

Role of lithium augmentation in the management of major depressive disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

Double-blind, placebo-controlled trial of the use of lithium to augment antidepressant medication in continuation treatment of unipolar major depression

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, part 1: update 2013 on the acute and continuation treatment of unipolar depressive disorders

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

Subjective response to and tolerability of long-term supraphysiological doses of levothyroxine in refractory mood disorders

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Acute and continuation treatment of major depressive disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 2: Maintenance treatment of major depressive disorder and treatment of chronic depressive disorders and subthre

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

Renal failure occurs in chronic lithium treatment but is uncommon

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

Do current screening recommendations allow for early detection of lithium-induced hyperparathyroidism in patients with bipolar disorder?

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

Lifestyle management of unipolar depression

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

Response, remission and drop-out rates following high-frequency repetitive transcranial magnetic stimulation (rTMS) for treating major depression: a systematic review and meta-analysis of randomized, double-blind and sham-controlled trials

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

A randomized clinical study of Lu AA21004 in the prevention of relapse in patients with major depressive disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

A different depression: clinical distinctions between bipolar and unipolar depression

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

Cognitive-behavioral therapy as continuation treatment to sustain response after electroconvulsive therapy in depression: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

Lithium in the treatment of major depressive disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

How long should the lithium augmentation strategy be maintained? A 1-year follow-up of a placebo-controlled study in unipolar refractory major depression.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

Maintenance study for adolescent depression

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

Delivering interventions for depression by using the internet: randomised controlled trial

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

Long-term lithium and mortality

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

Interpersonal psychotherapy for depression: a meta-analysis

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

Safety and efficacy of Vagus Nerve Stimulation in treatment-resistant depression. A systematic review

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

Impact of maintenance ECT on concentration and memory.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

Mood stabilizers in the prevention of recurrent affective disorders: a meta-analysis

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

Maintenance strategies for unipolar depression: an observational study of levels of treatment and recurrence.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

A consensus statement for safety monitoring guidelines of treatments for major depressive disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

Diagnostic conversions from major depressive disorder into bipolar disorder in an outpatient setting: results of a retrospective chart review

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

Systematic review and guide to selection of selective serotonin reuptake inhibitors

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

Australian and New Zealand clinical practice guidelines for the treatment of depression

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

Fluoxetine versus placebo in preventing relapse of major depression in children and adolescents.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

A practical guide to the use of repetitive transcranial magnetic stimulation in the treatment of depression

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

Number needed to treat to harm for discontinuation due to adverse events in the treatment of bipolar depression, major depressive disorder, and generalized anxiety disorder with atypical antipsychotics

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

Repetitive transcranial magnetic stimulation for treatment-resistant depression: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

Fluoxetine in the prevention of depressive recurrences: a double-blind study.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

Agomelatine prevents relapse in patients with major depressive disorder without evidence of a discontinuation syndrome: a 24-week randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

Escitalopram prevents relapse in older patients with major depressive disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

Methodologic issues in maintenance therapy clinical trials.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

Has the effectiveness of lithium changed? Impact of the variety of lithium's effects.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the treatment of acute bipolar depression

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term treatment of bipolar disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

Lithium Treatment Reduces Suicide Risk in Recurrent Major Depressive Disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

Antidepressant discontinuation syndromes

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

Can effects of antidepressants in patients with mild depression be considered as clinically significant?

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

Prophylactic effect of citalopram in unipolar, recurrent depression: placebo-controlled study of maintenance therapy

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

The clinical course of unipolar major depressive disorders

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

A prospective 12-year study of subsyndromal and syndromal depressive symptoms in unipolar major depressive disorders.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

Does incomplete recovery from first lifetime major depressive episode herald a chronic course of illness?

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

Lithium carbonate and imipramine in the prophylaxis of unipolar and bipolar II illness: a prospective, placebo-controlled comparison.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

Continuation and long-term maintenance treatment with Hypericum extract WS 5570 after recovery from an acute episode of moderate depression--a double-blind, randomized, placebo controlled long-term trial

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

Duloxetine 60 mg/day for the prevention of depressive recurrences: post hoc analyses from a recurrence prevention study

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression: a multisite study from the Consortium for Research in Electroconvulsive Therapy (CORE)

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. Introduction.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

Canadian Network for Mood and Anxiety Treatments (CANMAT) Clinical guidelines for the management of major depressive disorder in adults. IV. Neurostimulation therapies

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

Increasing rates of depression

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

Efficacy of citalopram in the prevention of recurrent depression in elderly patients: placebo-controlled study of maintenance therapy

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

A controlled family history study of childhood-onset depressive disorder.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. III. Pharmacotherapy.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

Adjunctive lithium treatment in the prevention of suicidal behaviour in depressive disorders: a randomised, placebo-controlled, 1-year trial

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

A randomized, placebo-controlled trial of sertraline for prophylactic treatment of highly recurrent major depressive disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

A systematic review of the clinical relevance of repetitive transcranial magnetic stimulation

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

Is it possible to evaluate true prophylactic efficacy of antidepressants in severely ill patients with recurrent depression? Lessons from a placebo-controlled trial. The fifth trial of the Danish University Antidepressant Group (DUAG-5).

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

Efficacy and tolerability of extended release quetiapine fumarate monotherapy as maintenance treatment of major depressive disorder: a randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

Lithium: a review of its metabolic adverse effects

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

Cognitive behavioural therapy for major psychiatric disorder: does it really work? A meta-analytical review of well-controlled trials

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

The lithiumeter: a measured approach

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

Lithium toxicity profile: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

Depressive disorders and suicide: Epidemiology, risk factors, and burden

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

The effect of long-term lithium treatment on the mortality of patients with manic-depressive and schizoaffective illness

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

Mortality during initial and during later lithium treatment. A collaborative study by the International Group for the Study of Lithium-treated Patients.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

Continuation/maintenance treatment with nortriptyline versus combined nortriptyline and ECT in late-life psychotic depression: a two-year randomized study.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

Atypical antipsychotic augmentation in major depressive disorder: a meta-analysis of placebo-controlled randomized trials

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

Individualized continuation electroconvulsive therapy and medication as a bridge to relapse prevention after an index course of electroconvulsive therapy in severe mood disorders: a naturalistic 3-year cohort study

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. II. Psychotherapy alone or in combination with antidepressant medication.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. I. Classification, burden and principles of management

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

Continuation and maintenance electroconvulsive therapy for mood disorders: review of the literature

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

The effect of mindfulness-based cognitive therapy for prevention of relapse in recurrent major depressive disorder: A systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

Cognitive status of psychiatric patients under maintenance electroconvulsive therapy: a one-year longitudinal study

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

Pattern of cognitive dysfunction in depressive patients during maintenance electroconvulsive therapy

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

Canadian Network for Mood and Anxiety Treatments (CANMAT) Clinical guidelines for the management of major depressive disorder in adults. V. Complementary and alternative medicine treatments.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

Chronic depression in the elderly: approaches for prevention.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression: a randomized controlled trial in patients older than 59 years.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

Vagus nerve stimulation (VNS) for treatment-resistant depressions: a multicenter study.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

Rapid effects of deep brain stimulation for treatment-resistant major depression

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

Lithium prophylaxis: myths and realities

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

Forty years of lithium treatment

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

Effects of antidepressant pharmacotherapy after repetitive transcranial magnetic stimulation in major depression: an open follow-up study

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

SSRIs, bone mineral density, and risk of fractures--a review

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

Antidepressant monotherapy vs sequential pharmacotherapy and mindfulness-based cognitive therapy, or placebo, for relapse prophylaxis in recurrent depression

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

Managing the risk of lithium-induced nephropathy in the long-term treatment of patients with recurrent affective disorders

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

What is the optimal serum lithium level in the long-term treatment of bipolar disorder--a review?

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

Exploratory meta-analysis on deep brain stimulation in treatment-resistant depression

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

Lithium treatment and prophylaxis in unipolar depression: a meta-analysis

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

Clinically significant pharmacokinetic drug interactions with carbamazepine. An update

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

Maintenance cognitive-behavioral therapy and manualized psychoeducation in the treatment of recurrent depression: a multicenter prospective randomized controlled trial

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

Change in mental health after smoking cessation: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

Comparing venlafaxine extended release and fluoxetine for preventing the recurrence of major depression: results from the PREVENT study.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

Effect of prophylactic treatment on suicide risk in patients with major affective disorders. Data from a randomized prospective trial

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

The effect of rate of antidepressant tapering on the incidence of discontinuation symptoms: a randomised study

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

Risk factors for antidepressant-related switch to mania.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

Therapeutic options in treatment-resistant depression

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

Head to head comparisons as an alternative to placebo-controlled trials.

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

Reducing relapse and recurrence in unipolar depression: a comparative meta-analysis of cognitive-behavioral therapy's effects

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

Effects of maintenance electroconvulsive therapy on cognitive functions

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

The course of depression in adult outpatients. Results from the Medical Outcomes Study

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

Relapse prevention in major depressive disorder after successful ECT: a literature review and a naturalistic case series

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

Selective serotonin reuptake inhibitor use and bone mineral density in women with a history of depression

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

Older community residents with depression: long-term treatment with sertraline. Randomised, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

The P revention of R ecurrent E pisodes of Depression with Ven lafaxine for T wo Years (PREVENT) Study: Outcomes from the Acute and Continuation Phases

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

Family psychoeducation for major depression: randomised controlled trial

1 reference

https://api.crossref.org/works/10.3109%2F15622975.2014.1001786

21 January 2018

Identifiers

10.3109/15622975.2014.1001786

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35560309&oldid=1861317713"